Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Caribou Biosciences, Inc. (NASDAQ: CRBU)
CRBU Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
5.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
181.30%
CRBU Stock Analysis
CRBU
PE Ratio:
CRBU
PEG Ratio:
Not Available
CRBU
Forward EPS Growth (12 month):
0.00%
CRBU
PS Ratio:
22.5
CRBU
PSG Ratio:
1.3
CRBU
Forward Revenue Growth (12 month):
17.60%
CRBU Articles
No data was found